Search Results - Colonization
Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 9
- Colonic Neoplasms
- Colon (Anatomy) 7
- Neoplasms 7
- Breast 5
- Breast Neoplasms 5
- Chemotherapy 5
- drug therapy 5
- genetics 5
- therapy 5
- Biochemical markers 3
- Biomarkers 3
- Genetic aspects 3
- Microsatellite Instability 3
- Neoplasms, Germ Cell and Embryonal 3
- Treatment 3
- Treatment Outcome 3
- Tumor Markers, Biological 3
- Tumor markers 3
- diagnosis 3
- Antineoplastic Agents 2
- Cadherins 2
- Cell- and Tissue-Based Therapy 2
- Cellular signal transduction 2
- Cytotoxicity, Immunologic 2
- Epidermal growth factor 2
- ErbB Receptors 2
- Etiology 2
- Gastrointestinal Neoplasms 2
- Immunotherapy 2
-
1
Role of molecular markers in guiding therapy in cancer
Published 2015Table of Contents: “…Contents: Prognostic biomarkers in breast cancer -- Microsatellite instability (MSI) in colon cancer -- Markers for metastatic germ cell cancers -- Systemic treatments for cancer therapies -- Therapy predictive markers -- Toxicity markers -- Determining treatment effectivity -- Caveats in use of markers in therapy -- Current vs. future approach to cancer management.…”
Get full text
Series
Electronic Video -
2
Cancer pathology
Published 2020Table of Contents: “…Contents: Cancer pathology -- Histology -- Melanoma -- GI colon cancer -- Breast cancer.…”
Get full text
Series
Electronic Video -
3
Cancer pathology
Published 2020Table of Contents: “…Contents: Cancer pathology -- Histology -- Melanoma -- GI colon cancer -- Breast cancer.…”
Get full text
Series
Electronic Video -
4
EGF receptor family targets for improving cancer therapy /
Published 2021Table of Contents: “…Contents: EGFR family members and cancer -- EGFR signalling in the oncogenic processes -- EGFR family structural biology -- ErbB2 and ErbB3 signalling -- EGFR dimer oligomerization -- PI3 kinase pathway -- E-cadherin -- EGFR inhibitors and antagonists -- Colon cancer treatments.…”
Get full text
Series
Electronic Video -
5
EGF receptor family targets for improving cancer therapy /
Published 2021Table of Contents: “…Contents: EGFR family members and cancer -- EGFR signalling in the oncogenic processes -- EGFR family structural biology -- ErbB2 and ErbB3 signalling -- EGFR dimer oligomerization -- PI3 kinase pathway -- E-cadherin -- EGFR inhibitors and antagonists -- Colon cancer treatments.…”
Get full text
Series
Electronic Video -
6
Role of molecular markers in guiding therapy in cancer
Published 2015Table of Contents: “…Contents: Prognostic biomarkers in breast cancer -- Microsatellite instability (MSI) in colon cancer -- Markers for metastatic germ cell cancers -- Systemic treatments for cancer therapies -- Therapy predictive markers -- Toxicity markers -- Determining treatment effectivity -- Caveats in use of markers in therapy -- Current vs. future approach to cancer management.…”
Get full text
Series
Electronic Video -
7
Role of molecular markers in guiding therapy in cancer
Published 2015Table of Contents: “…Contents: Prognostic biomarkers in breast cancer -- Microsatellite instability (MSI) in colon cancer -- Markers for metastatic germ cell cancers -- Systemic treatments for cancer therapies -- Therapy predictive markers -- Toxicity markers -- Determining treatment effectivity -- Caveats in use of markers in therapy -- Current vs. future approach to cancer management.…”
Get full text
Series
Electronic Video -
8
Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
Published 2021Table of Contents: “…Contents: Cancer immunity and adoptive cell therapy -- CAR-T and TCR-based therapy treating solid tumours -- Examples in osteosarcoma and colon cancer -- Transient CAR or TCR expression for safety evaluation -- Factors affecting in vivo efficacy and T-cell persistence -- A universal allogeneic therapeutic product.…”
Get full text
Series (Periodic reports)
Series (Immune system)
Electronic Video -
9
Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
Published 2021Table of Contents: “…Contents: Cancer immunity and adoptive cell therapy -- CAR-T and TCR-based therapy treating solid tumours -- Examples in osteosarcoma and colon cancer -- Transient CAR or TCR expression for safety evaluation -- Factors affecting in vivo efficacy and T-cell persistence -- A universal allogeneic therapeutic product.…”
Get full text
Series (Periodic reports)
Series (Immune system)
Electronic Video